SlideShare a Scribd company logo
CPCSEA Guidelines
A Seminar presented as a part of
I Year M. Pharm I semester Requirement
ACY 2019 – 20
By
M. Kavya Nainita
Regd. No. 19L81S0406
Pharmaceutical Quality Assurance,
Raghavendra Institute of Pharmaceutical
Education & Research (AUTONOMOUS),
Anantapuramu.
18-04-2020 1
CONTENTS
• CPCSEA - Definition
• Goals
• Objective
• Committee members
• Forms
• CPCSEA Annexures
• Animal procurement
• References
18-04-2020 2
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Introduction
• Committee for the Purpose of Control and
Supervision of Experiments on Animals.
• It is statutory committee.
• Established under Section 15 of the prevention
of cruelty to animals act 1960.
• Committee was reconstituted on 17 February,
2016.
18-04-2020 3
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
CPCSEA
Definition
Committee for the purpose of control and
supervision of experiments on animals.
• It is statutory body formed by the act of the Indian
Parliament under the Prevention of Cruelty to
Animals Act, 1960.
• The secretariat of CPCSEA has published its
guidelines, to ensure humane and ethical treatment of
animals, while carrying out legitimate scientific
research.
• It was formed in 1964.
• Headquarters is at Ballabhgarh of Faridabad district
in Haryana.
18-04-2020 4
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
GOAL
• To promote the humane care of animals used in
research.
• To provide specifications that will enhance animals
well being and quality of research.
• Effective functioning of IAEC.
• To provide guideline for:
Housing, care, breeding and maintenance.
Source of experimental animals
Acceptable experimental procedures for
anaesthesia and euthanasia.
OBJECTIVE
18-04-2020 5
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
COMMITTEE MEMBERS
• It is composed of
Members of the scientific
community
Regulatory authorities
Animal activists
The committee has 20 Experts
and 3 Official Members.
18-04-2020 6
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
1 Special Secretary / Additional Secretary, In-
charge of Animal Welfare, Government of
India, Ministry of Environment, Forest &
Climate Change, New Delhi
Chairman
2 Joint Secretary (Animal Welfare), Ministry
of Environment, Forest & Climate Change,
New Delhi
Vice Chairman
3 Representative from Drug Controller
General of India (DCGI), New Delhi
Member
4 Representative from Medical Council of
India (MCI), New Delhi
Member
5 Representative from Veterinary Council of
India (VCI), New Delhi
Member
18-04-2020 7
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
6 Representative from Pharmacy
Council of India (PCI), New Delhi
Member
7 Representative from University Grants
Commission (UGC), New Delhi
Member
8 Representative from Animal Welfare
Board of India (AWBI), Ballabhgarh
Member
9 Dr. Suresh Pothani, Representative
ICMR, Director In Charge & Scientist
“G” ICMR – National Animal
Resource Facility for Biomedical
Research, Hyderabad
Member
10 Prof. Asmita Gajbhiye, Professor &
Head, Dept of Pharmaceutical
Sciences, Dr. H.S. Gour
Vishwavidyalaya, Sagar
Member
18-04-2020 8
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
11 Prof. Alok Dhawan, Director, CSIR –
Indian Institute of Toxicology
Research, Lucknow
Member
12 Dr. Anurag Agrawal, Director, CSIR
– Institute of Genomics & Integrative
Biology, New Delhi
Member
13 Dr. Ram Vishwakarma, Director,
CSIR – Indian Institute of Integrative
Medicine, Jammu
Member
14 Dr. Pardeep Kumar Yadav, Senior
Veterinary Officer, All India Institute
of Medical Science, New Delhi
Member
15 Dr. S.G. Ramachandra, Chief
Research Scientist, Central Animal
Facility, Indian Institute of Science,
Bangalore
Member
18-04-2020 9
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
16 Dr. Subeer S. Majumdar, Director,
National Institute of Animal
Biotechnology, Hyderabad
Member
17 Prof. Dr. M. Ramachandra Mohan,
Professor, Dept of Zoology, Bangalore
University
Member
18 Prof. Madan Mohan Chaturvedi,
Professor and Head, Department of
Zoology, University of Delhi, New Delhi
Member
19 Prof. Aditya Kumar, Director, SKS
Institute, Mathura
Member
20 Director/Deputy Secretary (Animal
Welfare) Ministry of Environment,
Forests & Climate Change, New Delhi.
Member
18-04-2020 10
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Forms
Forms Purpose
FORM A [As per rule 5(a)] Application for Registration
with CPCSEA
Form B (per rule 8(a) Submission of Research
Protocol (s) on Large Animals
Form C Record of Animals bred /
acquired
Form D Record of Animals Acquired
and Experiments performed
FORM- E Record of animals sold
18-04-2020 11
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
IAEC
• Institutional animal ethical committee.
Definition:
• Body comprising of a group of persons
recognized and registered by the CPCSA.
Function:
• Review and approve all types of protocols for
research involving animal experimentation.
• Obtain the periodic reports on research
development and shall ensure visit to animal
house facility and laboratory.
18-04-2020 12
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Ministry of
Environment
and Forests
(Animal
Welfare)
CPCSEA
IAEC IBSC/IBC
Institutional Bio Safety Committee
18-04-2020 13
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
• Role of CPCSEA is to monitor animal.
Experiments through ethics committees set up
in institutions (IAEC).
• IAEC scrutinize all project proposals for
experimentation on animals.
For small animals- give the final
approval
For large animals-make its
recommendation to SCL
(Sub-Committee on Large
Animals)
18-04-2020 14
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Qualification
• B. V. Sc
• M.Sc. (Zoology/ Animal Sciences/ Animal
Biotechnology)
• M.Sc. / MTech (Life Sciences, Biological
Sciences/ Biochemistry/ Biotechnology/
Biomedical Engineering) with experience in
animal handling and animal research.
• M. Pharm with experience in animal handling
and animal research.
• MD/ MS with research experience in laboratory
animal handling.
18-04-2020 15
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
• Age limit: 65 years.
• Duration: 5 years.
• Inspection report of animal house with
photographs by IAEC members is required to
be sent once in a calendar year.
• If action is required, the facility must provide
within 30 days.
18-04-2020 16
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Veterinary care
•Adequate veterinary care must be provided and
is the responsibility of a veterinarian or a person
who has training or experience in laboratory
animal sciences and medicine.
•Observed regularly for sign of illness, injury or
abnormal behaviour.
•Contagious disease – isolated from healthy
animal.18-04-2020 17
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Surveillance, Diagnosis, Treatment
and Control of disease
(Annexure 1 and 2)
• All animals should be observed for signs of
illness, injury or abnormal behaviour by
animal house staff.
• Unexpected deaths and signs of illness,
distress or other deviations from normal health
conditions in animals.
18-04-2020 18
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Physical Relationship of Animal
Facilities to Laboratories
(Annexure-3)
• Separation of animal facilities from personnel
areas such as offices, conference rooms, and
other laboratories.
• Located away from dust, smoke, noise, wild
rodents, insects and birds.
• Animal rooms should occupy 50-60% of
constructed area.
18-04-2020 19
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Transport of laboratory animals (Annexure – 4)
Mouse Rat Hamster Guinea
pig
Rabbit Cat Dog Monkey
Max.no
Of
animals/
cage
25 25 25 12 2 1 or 2 1 or 2 1
Material
used in
transport
box
Metal
cardboard,
synthetic
material
metal metal Bamboo/
wood/metal
Space/
animal
(cm²)
Minimum
height of
box (cm)
20-25
12
80-
100
14
80-100
12
160-180
15
1000-
1200
30
1400-
1500
40
3000
50
2000-4000
48
18-04-2020 20
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
18-04-2020 21
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Anaesthesia
(Annexure-5)
• Sedatives, analgesics, anaesthetics should be used to
control pain or distress under experiment.
• Before using anaesthetics the animal is prepared for
anaesthesia by overnight fasting and using pre-
anaesthetics (scopolamine, atropine, diazepam, etc.)
• The animal should remain under veterinary care till it
completely recovers from anaesthesia and
postoperative stress.
Narcosis
Relaxation Analgesia18-04-2020 22
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Euthanasia
(Annexure-6)
• Death without causing anxiety, pain or distress
with minimum time lag phase.
• Done when an animal required to be sacrificed
or termination of an experiment or otherwise
for ethical reasons.
• Tranquilizers have to be administered to larger
species such as monkeys, dogs and cats before
an euthanasia procedure.
18-04-2020 23
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Animal care and Technical
Personnel
(Annexure-7)
• Animal care programs
• On-the-job training
• Trained person in laboratory animal science.
• Protective clothing (face masks, head covers,
aprons, gloves, gumboots, other footwear, etc.)
18-04-2020 24
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Animal Experimentation Involving
Hazardous Agents
(Annexure-8)
• Policies governing experimentation with
hazardous agents.
• Examine the proposal on animal experiments
involving hazardous agents.
• IBSC members are knowledgeable about
hazardous agents are in place in most of the
higher-level education, research institutes and in
many pharmaceutical industries for taking care of
safety issues.
18-04-2020 25
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Animal procurement
• All animals must be acquired lawfully as per
the CPCSEA guidelines.
• A health surveillance program for screening
incoming animals should be carried out to
assess animal quality.
• Each consignment of animals should be
inspected for compliance with procurement
specifications.
18-04-2020 26
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Quarantine
Definition:
• Separation of newly received animals until the
health and possibly the microbial status of
newly received animal have been determine.
• An effective quarantine minimizes the chance
for introduction of pathogens into an
established colony.
• Quarantine period :
 small lab animals- 1 week to 1 month.
 large lab animal – 6weeks.
18-04-2020 27
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Experimental area
• Experiments should be carried out in a
separate area away from the place where they
are housed.
• Separate functional areas for:
 surgical support
Treatment of animals
Post operative and
intensive care
18-04-2020 28
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Stabilization and Separation
• Physiologic, psychological and nutritional
stabilization should be given before their use.
• Separation is needed to prevent interspecies
diseases transmission and to eliminate anxiety
and possible physiological and behavioural
changes due to interspecies conflict.
• To prevent anxiety and behavioural changes.
18-04-2020 29
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Physical facilities
Building materials Durable, moisture – proof, fire
resistant and pest resistant.
corridors Movement of personnel and equipment
Animal room doors Fit properly, no rust
Exterior windows Not recommended
floors Smooth, moisture proof, non absorbent,
skid proof floors
drains Proper drainage, floors should be sloped
Storage areas For feed, bedding, cages
Temperature and humidity Between 18-29 °C and 30-70 %
ventilation Designed with 12-15 air cycles / hour
Power and lighting Fluorescent lights
noise control Noise free environment
Concrete walls are more effective.
18-04-2020 30
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Animal husbandry
Housing system:
Freedom of movement, normal
postural adjustments.
Comfortable environment
Easy access to food and water
Adequate ventilation
18-04-2020 31
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Food and water
Feed should contain Feed should not contain
Moisture Insecticides, hormones, antibiotics,
fumigants or toxicants
Crude fibre, protein, fat Heavy metals
Essential bits, minerals, carbohydrates
•Palatable
•Non-contaminated
•Nutritionally adequate
•Fresh
•Uncontaminated drinking water
18-04-2020 32
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Bedding
• Adsorbent, free from toxic chemicals.
• Should be removed and replaced periodically
with fresh materials.
• Ideal to change the bedding twice in a week.
• Newly delivered pups should be provided
wherever needed. (paper, cotton, etc.)
18-04-2020 33
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Transgenic animals
• Transgenic animals are those animals, into
whose germs line foreign genes have been
engineered.
Used for study of biological functions of
specific genes.
• Knockout animals are those specific genes
have been disrupted leading to loss of function.
Maintained in clean room environment or in
animal isolators.
18-04-2020 34
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Waste disposal
• Removed regularly and frequently.
• Disposed in a safe and sanitary manner.
• Preferred method – Incineration (thermal
treatment – waste materials converts waste into
ash, flue gas and heat).
• Waste cans containing animal tissue, carcasses
and hazardous wastes – leak proof.
• Cold storage might be necessary to prevent
decomposition of biological wastes.
18-04-2020 35
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Emergency, Weekend And Holiday
Care
• If any emergency, institutional security
personnel and fire or police officials should be
able to reach responsible persons for the
animals.
• Emergency veterinary care.
• Posting emergency procedures, names, or
telephone numbers in animals facilities in
security department.
18-04-2020 36
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Multiple surgical procedures on
single animal
• No animal should be used for experimentation
for more than 3 years unless adequate
justification is provided.
18-04-2020 37
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Breeding and Genetics
• The breeding stock must be procured from
CPCSEA registered breeders or suppliers
ensuring that genetic makeup and health status
of animal is known.
18-04-2020 38
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Record keeping
• Staff record- both technical and non-technical.
• Health record of staff animals.
• All SOP’s relevant to the animals.
• Breeding, stock, purchase and sales records.
• Records of experiments conducted with the
number of animals used.
• Death record
• Clinical record of sick animals.
• Training record of sick animals
• Training record of staff involved.
18-04-2020 39
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
Standard operating procedures
• Name of author
• Title of sop
• Date of preparation
• Reference of previous SOP
• Objectives
• Detailed information of instruments used in
animal methodology.(Model no., Serial no.)
• Normal value of all parameters
• Hazard identification and risk assessment.
18-04-2020 40
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
References
• CPCSEA.nic.in
• Appendix I of the New Zealand “Good Practice
Guide for the Use of Animals in Research, Testing
and Teaching” entitled “Pain: Some Concepts and
Definitions”.
• Derelanko MJ. The toxicologist's pocket
handbook. CRC Press; 2017 Nov 6.
• Olfert ED, Cross BM, McWilliam AA, editors.
Guide to the care and use of experimental
animals. Ottawa: Canadian Council on Animal
Care; 1993.
18-04-2020 41
PHARMACEUTICAL QUALITY ASSURANCE
RIPER
I'm so proud !
All of my kids
are going into
research.
18-04-2020 42
PHARMACEUTICAL QUALITY ASSURANCE
RIPER

More Related Content

What's hot

Institutional Animals Ethics Committee
Institutional Animals Ethics CommitteeInstitutional Animals Ethics Committee
Institutional Animals Ethics Committee
Shreya Gupta
 
Blood collection techniques from laboratory animals
Blood collection techniques from laboratory animalsBlood collection techniques from laboratory animals
Blood collection techniques from laboratory animals
Somasekhar Gupta
 

What's hot (20)

Euthanasia of experimental animals
Euthanasia of experimental animalsEuthanasia of experimental animals
Euthanasia of experimental animals
 
Cpcsea
CpcseaCpcsea
Cpcsea
 
Anaesthesia and euthanasia
Anaesthesia and euthanasiaAnaesthesia and euthanasia
Anaesthesia and euthanasia
 
CPCSEA GUIDELINE
CPCSEA GUIDELINE CPCSEA GUIDELINE
CPCSEA GUIDELINE
 
CPCSEA Guidelines ( Animal
CPCSEA Guidelines ( Animal CPCSEA Guidelines ( Animal
CPCSEA Guidelines ( Animal
 
Institutional Animals Ethics Committee
Institutional Animals Ethics CommitteeInstitutional Animals Ethics Committee
Institutional Animals Ethics Committee
 
Maintence and breeding of laboratory animals
Maintence and breeding of laboratory animalsMaintence and breeding of laboratory animals
Maintence and breeding of laboratory animals
 
CPCSEA guidelines for laboratory animal facility
CPCSEA guidelines for laboratory animal facilityCPCSEA guidelines for laboratory animal facility
CPCSEA guidelines for laboratory animal facility
 
Animal ethics committee in INDIA
Animal ethics committee in INDIAAnimal ethics committee in INDIA
Animal ethics committee in INDIA
 
CPCSEA- Guidelines
CPCSEA- GuidelinesCPCSEA- Guidelines
CPCSEA- Guidelines
 
Dose selection
Dose selectionDose selection
Dose selection
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
 
Blood collection techniques from laboratory animals
Blood collection techniques from laboratory animalsBlood collection techniques from laboratory animals
Blood collection techniques from laboratory animals
 
Alternatives to the use of animals in experimentations
Alternatives to the use of animals in experimentationsAlternatives to the use of animals in experimentations
Alternatives to the use of animals in experimentations
 
Oecd guidelines for toxicology studies
Oecd guidelines for toxicology studiesOecd guidelines for toxicology studies
Oecd guidelines for toxicology studies
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugs
 
Concept of glp
Concept of glpConcept of glp
Concept of glp
 
CPCSEA Guidelines for laboratory animal facility
CPCSEA Guidelines for laboratory animal facilityCPCSEA Guidelines for laboratory animal facility
CPCSEA Guidelines for laboratory animal facility
 
CIOMS (1).pptx
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptx
 
CPCSEA ppt final (S S C)
CPCSEA ppt final (S S C)CPCSEA ppt final (S S C)
CPCSEA ppt final (S S C)
 

Similar to Cpcsea ppt

Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Parul Institute of Pharmacy
 
CPCSEA.pptx
CPCSEA.pptxCPCSEA.pptx
CPCSEA.pptx
DharaMehta45
 
AALAS ALAT Chapter 2 Research Facility Environment
AALAS ALAT Chapter 2 Research Facility EnvironmentAALAS ALAT Chapter 2 Research Facility Environment
AALAS ALAT Chapter 2 Research Facility Environment
goodmatl
 
Pakistannationalanimalplanthealthinspectionservice2012i 120927200725-phpapp01
Pakistannationalanimalplanthealthinspectionservice2012i 120927200725-phpapp01Pakistannationalanimalplanthealthinspectionservice2012i 120927200725-phpapp01
Pakistannationalanimalplanthealthinspectionservice2012i 120927200725-phpapp01
Syed Amir Abbas Shah Naqvi
 
Veterinarian's Based Competencies on OIE - International Veterinary Student A...
Veterinarian's Based Competencies on OIE - International Veterinary Student A...Veterinarian's Based Competencies on OIE - International Veterinary Student A...
Veterinarian's Based Competencies on OIE - International Veterinary Student A...
Tata Naipospos
 

Similar to Cpcsea ppt (20)

Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
Animal Testing: Rationale for conducting studies, CPCSEA Guidelines
 
Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA Overview of ICH Guidelines, CPCSEA
Overview of ICH Guidelines, CPCSEA
 
CPCSEA .pptx
CPCSEA .pptxCPCSEA .pptx
CPCSEA .pptx
 
CPCSEA.pptx
CPCSEA.pptxCPCSEA.pptx
CPCSEA.pptx
 
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptx
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptxGLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptx
GLOBAL LAWS, REGULATION STANDARDS FOR ANIMALS IN.pptx
 
AALAS ALAT Chapter 2 Research Facility Environment
AALAS ALAT Chapter 2 Research Facility EnvironmentAALAS ALAT Chapter 2 Research Facility Environment
AALAS ALAT Chapter 2 Research Facility Environment
 
Pakistannationalanimalplanthealthinspectionservice2012i 120927200725-phpapp01
Pakistannationalanimalplanthealthinspectionservice2012i 120927200725-phpapp01Pakistannationalanimalplanthealthinspectionservice2012i 120927200725-phpapp01
Pakistannationalanimalplanthealthinspectionservice2012i 120927200725-phpapp01
 
ppt juris.hfydfafhvhfvdvfygfygfsygfsgfgf
ppt juris.hfydfafhvhfvdvfygfygfsygfsgfgfppt juris.hfydfafhvhfvdvfygfygfsygfsgfgf
ppt juris.hfydfafhvhfvdvfygfygfsygfsgfgf
 
Compendium of cpcsea
Compendium of cpcseaCompendium of cpcsea
Compendium of cpcsea
 
CPCSEA Guidelines Dr Santosh B Dighe.pdf
CPCSEA Guidelines Dr Santosh B Dighe.pdfCPCSEA Guidelines Dr Santosh B Dighe.pdf
CPCSEA Guidelines Dr Santosh B Dighe.pdf
 
International conventions and national regulation
International conventions  and  national regulationInternational conventions  and  national regulation
International conventions and national regulation
 
USFDA Over View
USFDA  Over ViewUSFDA  Over View
USFDA Over View
 
The Promise of Next-Generation Animal Management Systems
The Promise of Next-Generation Animal Management SystemsThe Promise of Next-Generation Animal Management Systems
The Promise of Next-Generation Animal Management Systems
 
GMP for Nutraceuticals...................
GMP for Nutraceuticals...................GMP for Nutraceuticals...................
GMP for Nutraceuticals...................
 
Food Control System in India
Food Control System in IndiaFood Control System in India
Food Control System in India
 
Assessment of food laws in India, UK and Thailand
Assessment of food laws in India, UK and ThailandAssessment of food laws in India, UK and Thailand
Assessment of food laws in India, UK and Thailand
 
Therapeutic Goods Administration
Therapeutic Goods Administration Therapeutic Goods Administration
Therapeutic Goods Administration
 
Antibiotic Residues In Milk, Risk For Consumers And Processors
Antibiotic Residues In Milk, Risk For Consumers And ProcessorsAntibiotic Residues In Milk, Risk For Consumers And Processors
Antibiotic Residues In Milk, Risk For Consumers And Processors
 
Veterinarian's Based Competencies on OIE - International Veterinary Student A...
Veterinarian's Based Competencies on OIE - International Veterinary Student A...Veterinarian's Based Competencies on OIE - International Veterinary Student A...
Veterinarian's Based Competencies on OIE - International Veterinary Student A...
 
Biosafety in food technology
Biosafety in food technologyBiosafety in food technology
Biosafety in food technology
 

Recently uploaded

Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
Avinash Rai
 

Recently uploaded (20)

Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Morse OER Some Benefits and Challenges.pptx
Morse OER Some Benefits and Challenges.pptxMorse OER Some Benefits and Challenges.pptx
Morse OER Some Benefits and Challenges.pptx
 
Salient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptxSalient features of Environment protection Act 1986.pptx
Salient features of Environment protection Act 1986.pptx
 
Application of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matricesApplication of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matrices
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
How to the fix Attribute Error in odoo 17
How to the fix Attribute Error in odoo 17How to the fix Attribute Error in odoo 17
How to the fix Attribute Error in odoo 17
 
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptxJose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfDanh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
 
Operations Management - Book1.p - Dr. Abdulfatah A. Salem
Operations Management - Book1.p  - Dr. Abdulfatah A. SalemOperations Management - Book1.p  - Dr. Abdulfatah A. Salem
Operations Management - Book1.p - Dr. Abdulfatah A. Salem
 
2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
size separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticssize separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceutics
 
Keeping Your Information Safe with Centralized Security Services
Keeping Your Information Safe with Centralized Security ServicesKeeping Your Information Safe with Centralized Security Services
Keeping Your Information Safe with Centralized Security Services
 
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General QuizPragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
 

Cpcsea ppt

  • 1. CPCSEA Guidelines A Seminar presented as a part of I Year M. Pharm I semester Requirement ACY 2019 – 20 By M. Kavya Nainita Regd. No. 19L81S0406 Pharmaceutical Quality Assurance, Raghavendra Institute of Pharmaceutical Education & Research (AUTONOMOUS), Anantapuramu. 18-04-2020 1
  • 2. CONTENTS • CPCSEA - Definition • Goals • Objective • Committee members • Forms • CPCSEA Annexures • Animal procurement • References 18-04-2020 2 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 3. Introduction • Committee for the Purpose of Control and Supervision of Experiments on Animals. • It is statutory committee. • Established under Section 15 of the prevention of cruelty to animals act 1960. • Committee was reconstituted on 17 February, 2016. 18-04-2020 3 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 4. CPCSEA Definition Committee for the purpose of control and supervision of experiments on animals. • It is statutory body formed by the act of the Indian Parliament under the Prevention of Cruelty to Animals Act, 1960. • The secretariat of CPCSEA has published its guidelines, to ensure humane and ethical treatment of animals, while carrying out legitimate scientific research. • It was formed in 1964. • Headquarters is at Ballabhgarh of Faridabad district in Haryana. 18-04-2020 4 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 5. GOAL • To promote the humane care of animals used in research. • To provide specifications that will enhance animals well being and quality of research. • Effective functioning of IAEC. • To provide guideline for: Housing, care, breeding and maintenance. Source of experimental animals Acceptable experimental procedures for anaesthesia and euthanasia. OBJECTIVE 18-04-2020 5 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 6. COMMITTEE MEMBERS • It is composed of Members of the scientific community Regulatory authorities Animal activists The committee has 20 Experts and 3 Official Members. 18-04-2020 6 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 7. 1 Special Secretary / Additional Secretary, In- charge of Animal Welfare, Government of India, Ministry of Environment, Forest & Climate Change, New Delhi Chairman 2 Joint Secretary (Animal Welfare), Ministry of Environment, Forest & Climate Change, New Delhi Vice Chairman 3 Representative from Drug Controller General of India (DCGI), New Delhi Member 4 Representative from Medical Council of India (MCI), New Delhi Member 5 Representative from Veterinary Council of India (VCI), New Delhi Member 18-04-2020 7 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 8. 6 Representative from Pharmacy Council of India (PCI), New Delhi Member 7 Representative from University Grants Commission (UGC), New Delhi Member 8 Representative from Animal Welfare Board of India (AWBI), Ballabhgarh Member 9 Dr. Suresh Pothani, Representative ICMR, Director In Charge & Scientist “G” ICMR – National Animal Resource Facility for Biomedical Research, Hyderabad Member 10 Prof. Asmita Gajbhiye, Professor & Head, Dept of Pharmaceutical Sciences, Dr. H.S. Gour Vishwavidyalaya, Sagar Member 18-04-2020 8 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 9. 11 Prof. Alok Dhawan, Director, CSIR – Indian Institute of Toxicology Research, Lucknow Member 12 Dr. Anurag Agrawal, Director, CSIR – Institute of Genomics & Integrative Biology, New Delhi Member 13 Dr. Ram Vishwakarma, Director, CSIR – Indian Institute of Integrative Medicine, Jammu Member 14 Dr. Pardeep Kumar Yadav, Senior Veterinary Officer, All India Institute of Medical Science, New Delhi Member 15 Dr. S.G. Ramachandra, Chief Research Scientist, Central Animal Facility, Indian Institute of Science, Bangalore Member 18-04-2020 9 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 10. 16 Dr. Subeer S. Majumdar, Director, National Institute of Animal Biotechnology, Hyderabad Member 17 Prof. Dr. M. Ramachandra Mohan, Professor, Dept of Zoology, Bangalore University Member 18 Prof. Madan Mohan Chaturvedi, Professor and Head, Department of Zoology, University of Delhi, New Delhi Member 19 Prof. Aditya Kumar, Director, SKS Institute, Mathura Member 20 Director/Deputy Secretary (Animal Welfare) Ministry of Environment, Forests & Climate Change, New Delhi. Member 18-04-2020 10 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 11. Forms Forms Purpose FORM A [As per rule 5(a)] Application for Registration with CPCSEA Form B (per rule 8(a) Submission of Research Protocol (s) on Large Animals Form C Record of Animals bred / acquired Form D Record of Animals Acquired and Experiments performed FORM- E Record of animals sold 18-04-2020 11 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 12. IAEC • Institutional animal ethical committee. Definition: • Body comprising of a group of persons recognized and registered by the CPCSA. Function: • Review and approve all types of protocols for research involving animal experimentation. • Obtain the periodic reports on research development and shall ensure visit to animal house facility and laboratory. 18-04-2020 12 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 13. Ministry of Environment and Forests (Animal Welfare) CPCSEA IAEC IBSC/IBC Institutional Bio Safety Committee 18-04-2020 13 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 14. • Role of CPCSEA is to monitor animal. Experiments through ethics committees set up in institutions (IAEC). • IAEC scrutinize all project proposals for experimentation on animals. For small animals- give the final approval For large animals-make its recommendation to SCL (Sub-Committee on Large Animals) 18-04-2020 14 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 15. Qualification • B. V. Sc • M.Sc. (Zoology/ Animal Sciences/ Animal Biotechnology) • M.Sc. / MTech (Life Sciences, Biological Sciences/ Biochemistry/ Biotechnology/ Biomedical Engineering) with experience in animal handling and animal research. • M. Pharm with experience in animal handling and animal research. • MD/ MS with research experience in laboratory animal handling. 18-04-2020 15 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 16. • Age limit: 65 years. • Duration: 5 years. • Inspection report of animal house with photographs by IAEC members is required to be sent once in a calendar year. • If action is required, the facility must provide within 30 days. 18-04-2020 16 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 17. Veterinary care •Adequate veterinary care must be provided and is the responsibility of a veterinarian or a person who has training or experience in laboratory animal sciences and medicine. •Observed regularly for sign of illness, injury or abnormal behaviour. •Contagious disease – isolated from healthy animal.18-04-2020 17 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 18. Surveillance, Diagnosis, Treatment and Control of disease (Annexure 1 and 2) • All animals should be observed for signs of illness, injury or abnormal behaviour by animal house staff. • Unexpected deaths and signs of illness, distress or other deviations from normal health conditions in animals. 18-04-2020 18 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 19. Physical Relationship of Animal Facilities to Laboratories (Annexure-3) • Separation of animal facilities from personnel areas such as offices, conference rooms, and other laboratories. • Located away from dust, smoke, noise, wild rodents, insects and birds. • Animal rooms should occupy 50-60% of constructed area. 18-04-2020 19 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 20. Transport of laboratory animals (Annexure – 4) Mouse Rat Hamster Guinea pig Rabbit Cat Dog Monkey Max.no Of animals/ cage 25 25 25 12 2 1 or 2 1 or 2 1 Material used in transport box Metal cardboard, synthetic material metal metal Bamboo/ wood/metal Space/ animal (cm²) Minimum height of box (cm) 20-25 12 80- 100 14 80-100 12 160-180 15 1000- 1200 30 1400- 1500 40 3000 50 2000-4000 48 18-04-2020 20 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 22. Anaesthesia (Annexure-5) • Sedatives, analgesics, anaesthetics should be used to control pain or distress under experiment. • Before using anaesthetics the animal is prepared for anaesthesia by overnight fasting and using pre- anaesthetics (scopolamine, atropine, diazepam, etc.) • The animal should remain under veterinary care till it completely recovers from anaesthesia and postoperative stress. Narcosis Relaxation Analgesia18-04-2020 22 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 23. Euthanasia (Annexure-6) • Death without causing anxiety, pain or distress with minimum time lag phase. • Done when an animal required to be sacrificed or termination of an experiment or otherwise for ethical reasons. • Tranquilizers have to be administered to larger species such as monkeys, dogs and cats before an euthanasia procedure. 18-04-2020 23 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 24. Animal care and Technical Personnel (Annexure-7) • Animal care programs • On-the-job training • Trained person in laboratory animal science. • Protective clothing (face masks, head covers, aprons, gloves, gumboots, other footwear, etc.) 18-04-2020 24 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 25. Animal Experimentation Involving Hazardous Agents (Annexure-8) • Policies governing experimentation with hazardous agents. • Examine the proposal on animal experiments involving hazardous agents. • IBSC members are knowledgeable about hazardous agents are in place in most of the higher-level education, research institutes and in many pharmaceutical industries for taking care of safety issues. 18-04-2020 25 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 26. Animal procurement • All animals must be acquired lawfully as per the CPCSEA guidelines. • A health surveillance program for screening incoming animals should be carried out to assess animal quality. • Each consignment of animals should be inspected for compliance with procurement specifications. 18-04-2020 26 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 27. Quarantine Definition: • Separation of newly received animals until the health and possibly the microbial status of newly received animal have been determine. • An effective quarantine minimizes the chance for introduction of pathogens into an established colony. • Quarantine period :  small lab animals- 1 week to 1 month.  large lab animal – 6weeks. 18-04-2020 27 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 28. Experimental area • Experiments should be carried out in a separate area away from the place where they are housed. • Separate functional areas for:  surgical support Treatment of animals Post operative and intensive care 18-04-2020 28 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 29. Stabilization and Separation • Physiologic, psychological and nutritional stabilization should be given before their use. • Separation is needed to prevent interspecies diseases transmission and to eliminate anxiety and possible physiological and behavioural changes due to interspecies conflict. • To prevent anxiety and behavioural changes. 18-04-2020 29 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 30. Physical facilities Building materials Durable, moisture – proof, fire resistant and pest resistant. corridors Movement of personnel and equipment Animal room doors Fit properly, no rust Exterior windows Not recommended floors Smooth, moisture proof, non absorbent, skid proof floors drains Proper drainage, floors should be sloped Storage areas For feed, bedding, cages Temperature and humidity Between 18-29 °C and 30-70 % ventilation Designed with 12-15 air cycles / hour Power and lighting Fluorescent lights noise control Noise free environment Concrete walls are more effective. 18-04-2020 30 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 31. Animal husbandry Housing system: Freedom of movement, normal postural adjustments. Comfortable environment Easy access to food and water Adequate ventilation 18-04-2020 31 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 32. Food and water Feed should contain Feed should not contain Moisture Insecticides, hormones, antibiotics, fumigants or toxicants Crude fibre, protein, fat Heavy metals Essential bits, minerals, carbohydrates •Palatable •Non-contaminated •Nutritionally adequate •Fresh •Uncontaminated drinking water 18-04-2020 32 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 33. Bedding • Adsorbent, free from toxic chemicals. • Should be removed and replaced periodically with fresh materials. • Ideal to change the bedding twice in a week. • Newly delivered pups should be provided wherever needed. (paper, cotton, etc.) 18-04-2020 33 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 34. Transgenic animals • Transgenic animals are those animals, into whose germs line foreign genes have been engineered. Used for study of biological functions of specific genes. • Knockout animals are those specific genes have been disrupted leading to loss of function. Maintained in clean room environment or in animal isolators. 18-04-2020 34 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 35. Waste disposal • Removed regularly and frequently. • Disposed in a safe and sanitary manner. • Preferred method – Incineration (thermal treatment – waste materials converts waste into ash, flue gas and heat). • Waste cans containing animal tissue, carcasses and hazardous wastes – leak proof. • Cold storage might be necessary to prevent decomposition of biological wastes. 18-04-2020 35 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 36. Emergency, Weekend And Holiday Care • If any emergency, institutional security personnel and fire or police officials should be able to reach responsible persons for the animals. • Emergency veterinary care. • Posting emergency procedures, names, or telephone numbers in animals facilities in security department. 18-04-2020 36 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 37. Multiple surgical procedures on single animal • No animal should be used for experimentation for more than 3 years unless adequate justification is provided. 18-04-2020 37 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 38. Breeding and Genetics • The breeding stock must be procured from CPCSEA registered breeders or suppliers ensuring that genetic makeup and health status of animal is known. 18-04-2020 38 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 39. Record keeping • Staff record- both technical and non-technical. • Health record of staff animals. • All SOP’s relevant to the animals. • Breeding, stock, purchase and sales records. • Records of experiments conducted with the number of animals used. • Death record • Clinical record of sick animals. • Training record of sick animals • Training record of staff involved. 18-04-2020 39 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 40. Standard operating procedures • Name of author • Title of sop • Date of preparation • Reference of previous SOP • Objectives • Detailed information of instruments used in animal methodology.(Model no., Serial no.) • Normal value of all parameters • Hazard identification and risk assessment. 18-04-2020 40 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 41. References • CPCSEA.nic.in • Appendix I of the New Zealand “Good Practice Guide for the Use of Animals in Research, Testing and Teaching” entitled “Pain: Some Concepts and Definitions”. • Derelanko MJ. The toxicologist's pocket handbook. CRC Press; 2017 Nov 6. • Olfert ED, Cross BM, McWilliam AA, editors. Guide to the care and use of experimental animals. Ottawa: Canadian Council on Animal Care; 1993. 18-04-2020 41 PHARMACEUTICAL QUALITY ASSURANCE RIPER
  • 42. I'm so proud ! All of my kids are going into research. 18-04-2020 42 PHARMACEUTICAL QUALITY ASSURANCE RIPER